Mar 11, 2024 02:45PM
Mar 11, 2024 02:43PM
Jun 2, 2023 12:11PM
May 22, 2023 07:40PM
Mar 2, 2023 10:14AM
Nov 14, 2022 02:12AM
Nov 14, 2022 02:10AM Indivior To Acquire Opiant Pharmaceuticals
Aug 25, 2022 12:32PM
Jan 27, 2022 03:56PM
Jun 8, 2021 07:30AM
Feb 23, 2021 07:00AM
Sep 24, 2020 02:30AM
Jul 24, 2020 10:35AM
Jul 11, 2019 05:15AM Indivior Raises FY 2019 Net Revenue and Net Income Guidance; Cash at H1 2019 Expected to be Approximately $985m
Jun 17, 2019 02:43PM
Apr 9, 2019 06:01PM
Apr 6, 2019 08:36AM
Apr 5, 2019 08:36AM
Mar 7, 2019 10:30AM
Feb 27, 2019 08:06AM
Feb 20, 2019 09:37AM Indivior Announces Launch of SUBOXONE® (buprenorphine and naloxone) Sublingual Film Authorized Generic
Feb 19, 2019 08:00AM
Jan 25, 2019 01:16PM
Jan 25, 2019 01:13PM
Jan 7, 2019 07:30AM
Dec 20, 2018 09:00AM
Dec 20, 2018 07:37AM
Dec 20, 2018 07:30AM Aquestive Therapeutics Provides End of Year Business Update, Including Progress of its Proprietary CNS Assets, Financial and Legal Matters
Dec 19, 2018 08:00AM
Dec 12, 2018 08:00AM
Nov 27, 2018 08:00AM
Nov 23, 2018 09:56AM
Nov 21, 2018 09:30AM
Nov 19, 2018 08:06AM
Oct 24, 2018 02:32PM Indivior Applauds Enactment of the SUPPORT for Patients and Communities Act of 2018
Sep 26, 2018 11:57AM
Sep 12, 2018 06:51AM
Sep 4, 2018 07:00AM
Aug 30, 2018 08:00AM
Jul 31, 2018 08:03AM
Jul 30, 2018 08:06AM
Jul 30, 2018 08:00AM DURECT Announces FDA Approval of Indivior's PERSERIS™ (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
Jul 27, 2018 07:44PM
Jul 13, 2018 06:22PM
Jul 11, 2018 07:47AM
Jun 15, 2018 08:00PM
Jun 15, 2018 10:11AM
May 31, 2018 08:45AM
May 25, 2018 09:55AM Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
May 14, 2018 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All